You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Not yet recruiting
  • Mantle Cell Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Mantle-cell Lymphoma Trial (Polatuzumab, bendamustin und rituximab)

    Not yet recruiting
    • Mantle-cell Lymphoma
    • Polatuzumab, bendamustin und rituximab
    • (no location specified)
    May 11, 2023

    Mantle Cell Lymphoma Trial in Miami, Houston (Zanubrutinib, Tafasitamab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Miami, Florida
    • +1 more
    Aug 31, 2023

    Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    Apr 18, 2023

    Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Nov 14, 2023

    Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

    Not yet recruiting
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    May 16, 2023

    Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

    Recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Nov 22, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Low Dose Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Oct 31, 2022

    Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Lymphoma, Mantle Cell
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 4, 2023

    Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Jul 26, 2023

    Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

    Recruiting
    • Lymphoma
    • Beijing, China
    • +2 more
    Oct 12, 2023

    Mantle Cell Lymphoma, Ketogenic Dieting Trial in New York (Ketogenic Diet)

    Recruiting
    • Mantle Cell Lymphoma
    • Ketogenic Dieting
    • Ketogenic Diet
    • New York, New York
      Weill Cornell Medicine
    Oct 17, 2022

    Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

    Not yet recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +2 more
    • Biopsy
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    May 15, 2023

    Mantle Cell Lymphoma Trial in Houston (Ibrutinib)

    Recruiting
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 1, 2022

    Mantle Cell Lymphoma Recurrent Trial in Melbourne (ibrutinib and Tisagenlecleucel)

    Active, not recruiting
    • Mantle Cell Lymphoma Recurrent
    • ibrutinib and Tisagenlecleucel
    • Melbourne, Victoria, Australia
      Peter Mac Callum Cancer Centre
    Nov 4, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Biospecimen Collection
    • Follow-Up
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • (no location specified)
    Jul 25, 2022

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

    Completed
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Determination of COVID-19 vacciantion efficacy
    • Rouen, France
      Centre Henri Becquerel
    Dec 22, 2022

    Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)

    Recruiting
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2022

    Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

    Active, not recruiting
    • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
    • +22 more
    • External Beam Radiation Therapy
    • Orbital Radiation
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    CCND1 Positive, Mantle Cell Lymphoma, t(11;14) Positive Trial in Atlanta, Johns Creek (Bendamustine, Obinutuzumab, Venetoclax)

    Active, not recruiting
    • CCND1 Positive
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Nov 2, 2022

    Recurrent Refractory Mantle Cell Lymphoma

    Recruiting
    • Mantle Cell Lymphoma
      • Beijing, Beijing, China
        Peking University Third Hospital
      Aug 1, 2022

      Mantle Cell Lymphoma, MCL Trial in United States (Tafasitamab, Lenalidomide)

      Recruiting
      • Mantle Cell Lymphoma
      • MCL
      • Basking Ridge, New Jersey
      • +6 more
      Mar 27, 2023